Hsp90 Inhibition on the Western Blot: N-Terminal Versus C-Terminal Inhibitors in Breast Cancer
{{output}}
Heat shock protein 90 (Hsp90) is an established and clinically validated anticancer target. By regulating the folding and maturation of diverse client proteins, it is indirectly involved in carcinogenesis. Key breast cancer oncogenic drivers, including estroge... ...
